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Abstract
Introduction: Tumor-associated macrophages, which are derived from the infiltration of circulating bone marrow-
derived monocytes, consist primarily of a polarized M2 macrophage (M2-Mj) population and are associated with
poor prognosis in various cancers. In the present study, we attempted to assess whether M2-Mjs derived from
bone marrow stimulate the promotion and progression of mammary tumors.
Methods: 4T1 murine mammary carcinoma cells were injected either alone or coupled with M2-Mjs into the
mammary fat pads of syngeneic female Balb/C mice. M2-Mjs were prepared by treating monocytes isolated from
female Balb/C mouse bone marrow with IL-4. Tumor cell growth was determined using an in vivo imaging system
and the expression of cell proliferation-related, angiogenesis-related, and lymphangiogenesis-related proteins in
tumor tissues was immunohistochemically analyzed. To evaluate the effects of the crosstalk between 4T1 cells and
M2-Mjs on the secretion and mRNA expression of cytokines and the migration of monocytes, 4T1 cells and M2-
Mjs were co-cultured and cytokine antibody array, real-time RT-PCR, and trans-well migration assays were
conducted.
Results: The co-injection of M2-Mjs into the mammary fat pads of mice increased solid tumor growth and lung
metastasis of 4T1 cells as well as the infiltration of CD45+ leukocytes into tumor tissues. The proportions of Ki-67+
proliferating cells and the expression of hypoxia inducible factor-1a, vascular endothelial cell growth factor A,
CD31, vascular endothelial cell growth factor C, and lymphatic vessel endothelial receptor-1 were increased
significantly in the tumor tissues of mice co-injected with 4T1 cells and M2-Mjs. The in vitro results revealed that
the proliferation of 4T1 cells, the migration of monocytes, and the secretion of granulocyte colony-stimulating
factor, IFNg, IL-1a, IL-2, IL-16, IFNg-induced protein-10, keratinocyte-derived chemokine, macrophage colony-
stimulating factor, monocyte chemotactic protein-1, macrophage inflammatory protein-1a, and RANTES were
increased when 4T1 cells were co-cultured with M2-Mjs, as compared with when the 4T1 cells were cultured
alone.
Conclusion: The crosstalk between 4T1 cells and M2-Mjs increased the production of cytokines, which may have
induced immune cell infiltration into tumor tissues, tumor cell proliferation, angiogenesis, and lymph angiogenesis,
thereby increasing solid tumor growth and lung metastasis.
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Introduction
Macrophages, which are derived from bone marrow pro-
genitors, are recruited into tissues to replace resident
populations or react to a variety of inflammatory and
immune stimuli. The differentiated phenotype of
recruited macrophages reflects signals from the micro-
environment in which they dwell. These macrophages
are broadly divided into two main classes; classically
activated macrophages, or alternatively activated macro-
phages (M2-Mjs). Classically activated macrophages
have immunostimulatory, T-helper type 1-orienting
properties and have an IL-1high, IL-6high, IL-12high, IL-
23high, TNFhigh, and IL-10low profile. By way of contrast,
M2-Mjs have an IL-1low, IL-6low, IL-12low, TNFlow, and
IL-10high profile, poor antigen-presenting capacity, and
are reported to suppress T-helper type 1 adaptive
immunity (reviewed in [1]).
Solid tumors consist of a number of cells, including
malignant cells, fibroblasts, endothelial cells, and
immune cells including macrophages. As cancer cells
generate chemotactic factors for monocytes, macrophage
accumulations were frequently observed in a variety of
cancers, including breast cancer [2-4]. Tumor microen-
vironments produce a variety of factors, which lead to
promotion of the differentiation and polarization of
infiltrated monocytes into M2-Mjs [5]. The macrophage
within the tumor, which is referred to as tumor-asso-
ciated macrophage (TAM), exhibits several pro-tumoral
functions, including the promotion of angiogenesis, the
suppression of adaptive immunity, and the expression of
growth factors and matrix proteases (reviewed in [1]).
Recent evidence has shown that TAM is associated with
poor prognosis in cancers, including breast cancer, lung
cancer, and pancreatic cancer [2,4,6]. In a mouse model
of mammary tumors initiated by the expression of the
polyoma virus middle T oncoprotein, the null mutation
in the colony-stimulating factor-1 gene CSF-1 to deplete
macrophages has been demonstrated to reduce the pro-
gression of preinvasive lesions to malignant lesions and
attenuate the formation of lung metastasis [7]. Using a
4T1 orthotopic Balb/C mammary cancer model in
which 4T1 mammary carcinoma cells were injected into
the mammary fat pads of syngeneic Balb/C mice, Luo
and colleagues have shown that a legumain-based DNA
vaccine targeting TAM suppressed tumor angiogenesis
and metastasis [8].
In this study, we evaluated the effect of M2-Mjs on
the promotion of mammary cancer using the 4T1-
orthotopic tumor model in which 4T1 mammary carci-
noma cells were injected in conjunction with M2-Mjs.
The 4T1 cell line was derived from a naturally occurring
mammary tumor in a Balb/C mouse [9] and thus the
inoculated 4T1 cells grow into solid tumors that
spontaneously metastasize to the lung, whereas the ori-
ginal tumor continues to grow in the mammary fat
pads. The 4T1 model is thus a physiological mouse
model that closely mimics breast cancer in humans
[9,10]. To prepare M2-Mjs, we isolated monocytes
from the bone marrow of female Balb/C mice and trea-
ted them with IL-4. The M2-Mjs and 4T1 cells are syn-
geneic in Balb/C mice, and - as opposed to immune-
deficient nude mice, which are extensively used as in
vivo tumor models - BALB/c mice are immune compe-
tent. This animal model is therefore useful in the study
of tumor growth and progression, in which the involve-
ment of the inflammatory/immune system is a critical
consideration.
We used an in vivo imaging system to estimate the
accumulation of 4T1 tumor cells in the solid tumor. To
quantify tumor cells, we engineered 4T1-luc cells that
stably and constitutively expressed a firefly luciferase
enzyme. The bioluminescence signal is derived from
viable 4T1-luc cells only, not from other cell types pre-
sent in a tumor such as fibroblasts, endothelial cells,
and immune cells. Additionally, the in vivo imaging sys-
tem is useful for repeatedly estimating the growth of a
solid tumor over the course of an experiment, with each
animal serving as its own reference. We demonstrated
that the co-injection of bone marrow-derived M2-Mjs
with 4T1 cells into mammary fat pads effectively stimu-
lated solid tumor growth and lung metastasis.
Materials and methods
Antibodies
The following antibodies were purchased from the sup-
pliers as indicated: antibodies against Ki-67, hypoxia-
inducible factor-1 alpha (HIF-1a), and lymphatic vessel
endothelial hyaluronan receptor-1 from Abcam (Cam-
bridge, UK); antibodies against cyclin-dependent kinase
(CDK)2, CDK4, vascular endothelial cell growth factor
(VEGF)-A, VEGF-C, and CD31 from Santa Cruz Bio-
technology (Santa Cruz, CA, USA); anti-CD45 antibody
from R&D Systems (Minneapolis, MN, USA); antibodies
against rabbit-IgG-Alexa488, rabbit-IgG-Alexa597, and
goat-IgG-Alexa488 from Invitrogen (Carlsbad, CA,
USA); and anti-goat-IgG-Cy3 antibody from Rockland
(Gibertsville, PA, USA). The primary and secondary
antibodies were used at a dilution of 1:200 and 1:1,000,
respectively.
Cell culture
The 4T1 cell line was purchased from the American
Type Culture Collection (Manassas, VA, USA). To
establish a 4T1 cell line that stably expresses firefly luci-
ferase (4T1-luc), the cells were infected with a lentiviral
vector harboring a gene encoding for firefly luciferase
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[11]. The 4T1 and 4T1-luc cell lines were maintained in
DMEM containing 10% FBS. The L929 murine fibrosar-
coma cell line was purchased from the Korean Cell Line
Bank (Seoul, Korea) and maintained in RPMI 1640 con-
taining 10% heat-inactivated FBS. All cultures contained
100 kU/l penicillin and 100 mg/l streptomycin.
Preparation of M2-Mjs derived from mouse bone marrow
Bone marrow cells were collected from the femoral
shafts of female Balb/C mice. Monocytes were isolated
from the bone marrow cell suspensions using the Easy-
Sep mouse monocyte negative-selection enrichment
mixture (StemCell Technologies, Vancouver, Canada) in
accordance with the manufacturer’s protocols. The iso-
lated monocytes were cultured and differentiated for 7
days in DMEM containing 10% heat-inactivated FBS
and 10% L929 cell-conditioned medium [12]. The cell
monolayers were then treated overnight with IL-4 to
induce differentiation into the M2 phenotype. To deter-
mine whether the macrophages evidence the characteris-
tics of M2-Mjs, the expression of macrophage mannose
receptors was routinely estimated via RT-PCR [13].
Animals and in vivo imaging system
Female Balb/C mice (3 weeks of age) were purchased
from Orient Bio Inc. (Gapyung, Korea) and were acclima-
tized to laboratory conditions at the animal research
facility of Hallym University, Chuncheon, Korea. All ani-
mal experimental protocols were approved by the Animal
Care and Use Committee of Hallym University (Hal-
lym2010-14). Balb/C mice were fed on an AIN-76A diet
(Research Diets, New Brunswick, NJ, USA) and water ad
libitum. After acclimatization, 4T1-luc cells (5 × 104
cells) and/or M2-Mjs (1 × 104 cells) were suspended in
0.1 ml Matrigel (BD Biosciences, San Jose, CA, USA) and
injected into the inguinal mammary fat pads of female
Balb/C mice (4 weeks of age, eight mice/group).
For the bioluminescence imaging, mice received an
intraperitoneal injection of 150 μl D-luciferin (30 mg/
ml). Fifteen minutes after the injection of D-luciferin,
the mice were anesthetized with isoflurane/oxygen and
placed on the imaging stage. The bioluminescence sig-
nals were monitored using an IVIS-200 (Xenogen Corp.,
Alameda, CA, USA). The data were analyzed using the
total photon flux emission (photons/second) in the
regions of interest.
Three weeks after 4T1 cell injection, mice were
anesthetized and the tumors were removed and
weighed. The lungs were fixed in Bouin’s solution, and
the metastases were quantified.
To determine whether immune cells in the tumor tis-
sues are derived from injected M2-Mjs or infiltrated cir-
culating leukocytes, a separate animal experiment was
conducted. For this experiment, M2-Mjs were labeled
with the green fluorescence-tagged lipophilic tracer 3,3’-
dioctadecyloxacarbocyanine perchlorate/DiOC18 (DiO;
Invitrogen) immediately prior to the injection. To accom-
plish this, the M2-Mjs were exposed to 50 μmol/l DiO
for 2 hours and were washed with PBS. The animals (five
mice/group) were sacrificed 2 weeks after the injection.
Immunohistochemical and immunofluorescence staining
For immunohistochemical staining, tumors were fixed in
4% paraformaldehyde and embedded in paraffin wax.
Sections of 5 μm were prepared from the paraffin-
embedded tumor blocks and hydrated through xylene
and graded alcohol. Antigen retrieval was performed by
microwaving the slides in 10 mmol/l sodium citrate buf-
fer (pH 6.0). Endogenous peroxidases were quenched
with 3% hydrogen peroxide for 5 minutes. Sections were
incubated with their relevant antibodies, and were then
developed using an LSAB kit (Dako, Carpinteria, CA,
USA) in accordance with the manufacturer’s instructions.
For immunofluorescence staining, tumors were
immersed in optimal cutting temperature compound
and frozen rapidly in liquid nitrogen. Then, 5 μm sec-
tions were cut with a cryostat microtome. Sections were
fixed with 4% paraformaldehyde, permeabilized with ice-
cold methanol, and incubated with their relevant antibo-
dies. Nuclei were counterstained with 4’,6-diamidino-2-
phenylindole.
Co-culture of 4T1 cells and M2-Mjs
To investigate the cytokine production, 4T1 cells (1 ×
105 cells/well) were plated in 12-well plates with or
without M2-Mjs (2 × 104 cells/well). After 24 hours,
cells were serum starved for 24 hours with DMEM.
After serum starvation, cells were incubated in fresh
DMEM for a further 24 hours, and the 24-hour-condi-
tioned media were collected. Four independent experi-
ments were conducted and the conditioned media were
pooled. The relative levels of cytokines in the pooled
conditioned media were measured via a mouse cytokine
array panel A kit (ARY006) in accordance with the man-
ufacturer’s instructions (R&D Systems). Densitometric
analysis was conducted using the Bioprofile BioID appli-
cation (Vilber Lourmat, Marne-la-Vallée, France).
Expression levels were normalized to the levels of the
positive control spots (contained within the membrane),
and the positive control levels were set at 100%.
To determine the expression of cytokine mRNAs in a
co-culture model, 4T1 cells or M2-Mjs were plated on
cell culture coverslips (24 mm × 30 mm) in eight-well
plates (Nunc Inc., Rochester, NY, USA). After 24 hours,
two coverslips (covered with the monolayers of 4T1
cells or M2-Mjs) were placed in the same wells of four-
well plates (4T1 + 4T1; 4T1 + M2-Mjs; or M2-Mjs +
M2-Mjs) and incubated in fresh DMEM for 24 hours.
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The total RNAs of each cell type were isolated using an
RNeasy Plus Mini Kit (Qiagen, Valencia, CA, USA), and
the real-time RT-PCR was conducted as previously
described [14]. The sequences for PCR primer sets are
listed in Table 1. The control levels (4T1 cells alone or
M2-Mjs cells alone) were set at 1.
Trans-well migration assays of bone marrow-derived
monocytes
Monocytes were isolated as described above and plated
onto the type IV collagen-coated filter (3 μm pore size) in
6.5-mm trans-well inserts at 1 × 105 cells. The lower
chamber of the well was filled with or without media con-
ditioned by 4T1 cells and/or M2-Mjs. Monocytes were
incubated for 1 hour. Migrated cells were stained with
4’,6-diamidino-2-phenylindole and were quantified by
counting the 4’,6-diamidino-2-phenylindole-stained cells.
Statistical analysis
The results are expressed as the mean ± standard error
of the mean. Differences between groups were assessed
via the Student’s t test and Duncan’s multiple-range
test, utilizing SAS statistical software, version 8.12 (SAS
Institute, Cary, NC, USA).
Results
M2-Mjs stimulate the solid tumor growth of 4T1 mam-
mary cancer cells in Balb/C mice
To determine whether M2-Mjs stimulate the growth of
mammary cancer cells in vivo, we injected 4T1-luc cells
into the mammary fat pads of Balb/C either alone or
coupled with M2-Mjs. Prior to the injection, the levels of
macrophage mannose receptor transcripts were estimated
via RT-PCR in order to determine whether the IL-4-trea-
ted cells exhibit an M2 phenotype. IL-4 treatment effec-
tively induced the mRNA expression of the macrophage
mannose receptor (data not shown). At the indicated time
point after the tumor cell inoculation, all mice were
scanned with the IVIS-200 system (Xenogen Corp.) and
each bioluminescent signal was calculated. At 2 days after
the inoculation, there was no significant difference in the
bioluminescent signals between the two groups. Co-injec-
tion with M2-Mjs significantly increased bioluminescent
signals at 9 days after the inoculation and the increase in
bioluminescent signals was more pronounced at 16 days
(Figure 1A,B). These results clearly demonstrate that the
accumulation of 4T1 cancer cells in the mammary fat
pads was increased significantly when the 4T1 cells were
co-injected with M2-Mjs as compared with when 4T1
cells were injected alone. In a different experiment (10
mice/group) we measured tumor volumes and weights,
which were noted to be increased when 4T1 cells were co-
injected with M2-Mjs (data not shown).
As the tumor growth was increased in mice co-
injected with 4T1 cells and M2-Mjs, we subsequently
evaluated the effects of M2-Mjs on the expression
levels of proteins involved in cell proliferation via immu-
nohistochemistry. As compared with mice injected with
4T1 cells alone, the proportions of Ki-67-positive cells
(Ki-67 is a nucleoprotein expressed only in cycling cells)
and the expression of CDK2 and CDK4 were increased
significantly in mice co-injected with M2-Mjs (Figure
1C). To determine whether M2-Mjs stimulate 4T1 cell
proliferation, an in vitro study was conducted by cultur-
ing 4T1-luc cells alone or with M2-Mjs. A positive cor-
relation was noted between 4T1-luc cell numbers and
bioluminescent signals (R2 = 0.9988). Bioluminescent
signals were significantly increased when the 4T1-luc
cells were co-cultured for 4 days with M2-Mjs com-
pared with when 4T1-luc cells were cultured alone, indi-
cating that the crosstalk between the two cell types
induces the proliferation of 4T1 cells (Figure 1D).
M2-Mjs induce an increase in lung metastasis of 4T1
mammary cancer cells in Balb/C mice
To assess the effect of M2-Mjs on the lung metastasis
of mammary cancer cells, 4T1-cell-bearing mice were
sacrificed at 3 weeks after the inoculation, the lungs
were fixed in Bouin’s solution, and the metastases were
quantified. At this time, tumor nodules were detected in
all animals injected with 4T1 cells. The number and
volume of lung tumor nodules per mouse were
increased significantly in animals co-injected with M2-
Mjs (Figure 2A to 2C).
Table 1 Primer sequences used for real-time RT-PCR
mRNA Primer sequences Reference
M-CSF Forward: 5’-TTGGCTTGGGATGATTCTCAG-3’ [28]
Backward: 5’-GCCCTGGGTCTGTCAGTCTC-3’
IP-10 Forward: 5’-CCCACGTGTTGAGATCATTG-3’ [29]
Backward: 5’-GCTCTCTGCTGTCCATCCAT-3’




G-CSF Forward: 5’-CATGGCTCAACTTTCTGCCCA-3’ [31]
Backward: 5’-TAGGTGGCACACAACTGCTC-3’
IL-1a Forward: 5’-AAGACAAGCCTGTGTTGCTGAAGG-3’ [32]
Backward: 5’-CCAGAAGAAAATGAGGTCGGTC-3’
KC Forward: 5’-CAAGAACATCCAGAGCTTGAAGGT-3’ [33]
Backward: 5’-GTGGCTATGACTTCGGTTTGG-3’
MIP-1a Forward: 5’-ACCATGACACTCTGCAACCA-3’ [34]
Backward: 5’-CCCAGGTCTCTTTGGAGTCA-3’
G-CSF, granulocyte colony-stimulating factor; HIF-1a, hypoxia-inducible factor-
1a; IP-10, IFNg-induced protein-10; KC, keratinocyte chemoattractant; M-CSF,
macrophage colony-stimulating factor; MCP-1, monocyte chemotactic protein-
1; MIP-1a, macrophage inflammatory protein-1 alpha; RANTES, regulated upon
activation, normal T-cell expressed and secreted.
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Figure 1 M2-polarized macrophages enhance tumor growth and increase cell proliferation indices. 4T1-luc cells and/or M2-polarized
macrophages (M2-Mjs) were injected into the mammary fat pads of female Balb/C mice. Bioluminescent signals were monitored on the days
indicated. (A) Representative images of luciferase signals. (B) Quantitative analysis of luminescence. Each bar represents the mean ± standard
error of the mean (SEM) (n = 8). (C) Immunohistochemical (IHC) staining for Ki-67, cyclin-dependent kinase (CDK)2, and CDK4 in tumor sections
was based on 3,3’-diaminobenzidine staining, as described in the Materials and methods section. (D) 4T1-luc cells and/or M2-Mjs were cultured
in 24-well plates. Bioluminescent signals were monitored at the indicated day. Each bar represents the mean ± SEM from three independent
experiments performed in duplicate. *Significantly different from the 4T1 group, P < 0.05.
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Figure 2 M2-polarized macrophages enhance lung metastasis of 4T1 cells in the 4T1 orthotopic mouse tumor model. 4T1 cells and/or
M2-polarized macrophages (M2-Mjs) were injected into the mammary fat pads of female Balb/C mice. After 3 weeks, the mice were killed and
the lungs were removed and fixed in Bouin’s solution. (A) Photographs of lung metastasis. (B), (C) Quantitative analysis of lung tumor nodules.
Each bar represents the mean ± standard error of the mean (n = 8). *Significantly different from the group injected with 4T1 cells alone, P <
0.05. (D) Tumor sections were stained with their relevant antibodies as described in the Materials and methods section. Photographs of
immunohistochemical or immunofluorescent staining, which are representative of six different animals, are shown. HIF-1a, hypoxia-inducible
factor-1 alpha; VEGF, vascular endothelial growth factor; LYVE-1, lymphatic vessel endothelial hyaluronan receptor-1.
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HIF-1a activates the transcription of multiple genes
including VEGF-A, a key factor in tumor angiogenesis.
The accumulation of HIF-1a in the nuclei of tumor
cells was increased in mice co-injected with 4T1 cells
and M2-Mjs (Figure 2D). Co-inoculation of M2-Mjs
increased the expression of VEGF-A as well as the pro-
portions of CD31-positive cells (CD31 is a glycoprotein
expressed on endothelial cells and in platelets) (Figure
2D). Additionally, the co-inoculation of M2-Mjs
increased the expression of the lymphangiogenic growth
factor VEGF-C and lymphatic vessel endothelial hyalur-
onan receptor-1-positive vessels.
Crosstalk between 4T1 cells and M2-Mjs increases the
infiltration of monocytes into tumor tissues in Balb/C
mice
In an effort to determine whether the co-injection of
M2-Mjs induces the infiltration of circulating mono-
cytes into tumor tissues, M2-Mjs were labeled with the
green fluorescence-tagged, lipophilic tracer DiO imme-
diately before being injected. At 2 weeks after the tumor
cell injection, the injected M2-Mjs (green color) were
observed only in the central area of the tumor. Tumor
sections were stained with a red fluorescence-tagged
CD45 antibody. CD45+ cells (red color) were distributed
diffusely throughout the tumor area and increased in
mice co-injected with 4T1 cells and M2-Mjs (Figure
3A). Additionally, in vitro trans-well migration assay
results revealed that the migration of bone marrow-
derived monocytes was tremendously elevated when
medium conditioned by 4T1/M2-Mj co-cultures was
used as a chemoattractant, as compared with medium
conditioned by 4T1 cells or M2-Mjs alone (Figure 3B).
Crosstalk between 4T1 cells and M2-Mjs stimulates
cytokine production
The results of the mouse cytokine antibody array ana-
lyses indicated that the levels of granulocyte colony-sti-
mulating factor (G-CSF), IFNg, IL-1a, IL-2, IL-16, IFNg-
induced protein-10 (IP-10), keratinocyte-derived chemo-
kine (KC), macrophage colony-stimulating factor (M-
CSF), monocyte chemotactic protein-1 (MCP-1), macro-
phage inflammatory protein-1a (MIP-1a), and regulated
upon activation, normal T-cell expressed and secreted
(RANTES) were increased in the media conditioned by
the co-culture of 4T1 cells and M2-Mjs (Figure 4A).
The results of real-time RT-PCR demonstrated that the
expression of M-CSF, IP-10, and RANTES mRNAs
increased in 4T1 cells when 4T1 cells were co-cultured
with M2-Mjs as compared with when 4T1 cells were
cultured alone. In M2-Mjs, the mRNA expression of G-
CSF, IL-1a, KC, and MIP-1a were increased when M2-
Mjs were co-cultured with 4T1 cells as compared with
when M2-Mjs cells were cultured alone. The expression
of MCP-1 mRNA increased in both 4T1 cells and M2-
Mjs upon co-culture (Figure 4B). These results demon-
strate that interactions between 4T1 cells and M2-Mjs
increase the production of a variety of chemoattractants,
resulting in increases in tumor cell proliferation and
monocyte migration.
Discussion
The tumor microenvironment consists of several com-
ponents, including malignant cells, stromal cells, extra-
cellular matrix, endothelial cells, and infiltrating
leukocytes. TAM is frequently found to constitute a
major part of the leukocyte infiltrates present in the
tumor microenvironment (reviewed in [1]). Extensive
infiltration of TAM has been shown to be positively
associated with poor prognosis in breast cancer
(reviewed in [15]) and high numbers of TAMs correlate
with increased tumor angiogenesis and involvement of
local lymph nodes in breast cancer patients [16,17].
Emerging evidence indicates that, in the tumor microen-
vironment, tumor cells affect the differentiation and
functional orientation of TAM. In turn, TAMs function
as a key regulator in the tumor microenvironment and
evidence several characteristics of M2-Mjs: the suppres-
sion of inflammatory responses and adaptive immunity,
the repair and modeling of wounded and damaged tis-
sues, and the promotion of angiogenesis (reviewed in
[18]). However, there is evidence showing that the phe-
notype of TAMs is pliable and varies among tumor
types, stages of tumor development, and the location of
TAMs in the tumor microenvironment (that is, the
response of TAMs to local signals) (reviewed in [19]).
Understanding the roles of the specific phenotype of
macrophages on tumor promotion and tumor progres-
sion is therefore important. In the present study, we
demonstrated that the co-injection of M2-Mjs with
mammary carcinoma cells into the mammary fat pad of
syngeneic Balb/C mice increased solid tumor growth
and lung metastasis.
In the present study, the injected green M2-Mjs were
confined to the center of the tumor tissues, whereas the
CD45+ leukocytes were detected diffusely throughout
the tumor tissues and increased in animals co-injected
with M2-Mjs as compared with those in mice injected
with 4T1 cells alone (Figure 3A). Our results indicate
that the injected macrophages were not proliferating in
the tumors. Indeed, in a preliminary experiment, when
M2-Mjs were injected alone, we were unable to detect
any solid mass 3 weeks after the injection when the
mice were sacrificed. These results demonstrate that the
crosstalk between tumor cells and M2-Mjs increases
the production of chemoattractants for the infiltration
of circulating leukocytes. Additionally, the media condi-
tioned by co-culture of 4T1 and M2-Mjs profoundly
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Figure 3 M2-polarized macrophages enhance leukocyte infiltration into tumor tissues and monocyte migration in vitro. (A) 4T1 cells
and/or M2-polarized macrophages (M2-Mjs) were injected into the mammary fat pad of female Balb/C mice. M2-Mjs were labeled with 3,3’-
dioctadecyloxacarbocyanine perchlorate/DiOC18 (DiO) (green) prior to the injection. Cryostat sections of tumor were stained with anti-CD45
antibody (red), and nuclei were counterstained with 4’,6-diamidino-2-phenylindole (DAPI) (blue). (B) 4T1 cells and/or M2-Mjs were plated in 12-
well plates, and 24-hour-conditioned media (CM) were collected for trans-well migration assays. The migration of bone marrow-derived
monocytes was estimated using the CM as a chemoattractant. The migrated monocytes were quantified by counting the DAPI-stained cells.
Each bar represents the mean ± standard error of the mean of three independent experiments performed in duplicate. Means without the same
lowercase letter differ, P < 0.05.
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induced the migration of bone marrow-derived mono-
cytes (Figure 3B). The co-culture conditioned media
contained higher concentrations of G-CSF, IFNg, IL-1a,
IL-2, IL-16, IP-10, KC, M-CSF, MCP-1, MIP-1a, and
RANTES as compared with media conditioned by 4T1
cells alone (Figure 4A). These cytokines may have
induced the infiltration of circulating monocytes into
the tumor tissues and/or the stimulation of mammary
Figure 4 Crosstalk between 4T1 cells and M2-polarized macrophages stimulates cytokine production. (A) 4T1 cells and/or M2-polarized
macrophages (M2-Mjs) were plated in 12-well plates, and 24-hour-conditioned media (CM) were collected. Four independent experiments were
conducted and the CM were pooled. The relative levels of cytokines in the pooled CM were estimated using a mouse cytokine array panel A kit.
Expression levels were normalized to the levels of the positive control spots (contained within the membrane), and the positive control levels
were set at 100%. (B) 4T1 cells or M2-Mjs were plated on cell culture coverslips (24 mm × 30 mm) in eight-well plates. After 24 hours,
coverslips (containing 4T1 cells or M2-Mjs) were placed on the same wells of four-well plates (4T1 + 4T1; 4T1 + M2-Mjs; or M2-Mjs + M2-Mjs)
for 24 hours. Total RNA was isolated, and real-time RT-PCR was performed. Results are shown as means ± standard error of the mean of three
independent experiments performed in duplicate. Each of the control levels (4T1 cells alone or M2-Mjs alone) was set to 1. G-CSF, granulocyte
colony-stimulating factor; IP-10, IFNg-induced protein-10; KC, keratinocyte chemoattractant; M-CSF, macrophage colony-stimulating factor; MCP-1,
monocyte chemotactic protein-1; MIP-1a, macrophage inflammatory protein-1 alpha; RANTES, regulated upon activation, normal T-cell expressed
and secreted.
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cancer cell proliferation and metastasis in these mice.
The ability of MCP-1, MIP-1a, and RANTES to induce
the migration of human blood monocytes has been
reported previously [20]. Additionally, we have pre-
viously demonstrated that M-CSF stimulated the adhe-
sion and migration of 4T1 cells under in vitro
conditions [21]. The crosstalk between the two types of
cells induced the mRNA expression of M-CSF, IP-10,
RANTES, and MCP-1 in 4T1 cells and that of G-CSF,
IL-1a, KC, MCP-1, and MIP-1a in M2-Mjs (Figure
4B). Recently, Kim and colleagues reported that the con-
ditioned medium of 4T1 cells induced the release of IL-
6 and TNFa in bone marrow-derived macrophages [22].
In the media conditioned by 4T1 cells and a 4T1/M2-
Mj co-culture, IL-6 was not detected and the co-culture
induced no increase in the concentration of TNFa (data
not shown). The differences between the two studies are
probably attributable to differences in experimental con-
ditions. In this study, we used a co-culture of 4T1 and
IL-4-treated M2-Mjs, whereas Kim and colleagues cul-
tured bone marrow-derived macrophages in media con-
ditioned by 4T1 cells [22]. Future studies will be
required to delineate specifically which cytokines/che-
mokines are responsible for the increases in the prolif-
eration of 4T1 cells and the infiltration of circulating
monocytes into tumor tissues.
Immunohistochemical staining of tumor sections
revealed that the proportions of Ki-67-positive cells and
the expression of CDK2 and CDK4 were increased in
mice co-injected with 4T1 cells and M2-Mjs (Figure
1C). Moreover, the accumulation of bioluminescent sig-
nal of 4T1-luc cells was tremendously more pronounced
in mice co-injected with M2-Mjs (Figure 1A,B).
Furthermore, in vitro co-cultures of these two cell types
revealed that 4T1 cell growth was increased in the pre-
sence of M2-Mjs (Figure 1D). The mammalian cell
cycle is divided into four separate phases - the G1
phase, the S phase, the G2 phase, and the M phase -
and transit through the cell cycle depends on sequential
activation of CDKs. Activation of CDK4 appears to gov-
ern exit from the G0 phase and entry into an early G1
phase, and activation of CDK2 regulates transition into
and passage through the S phase [23]. Overexpression
of CDK2 and CDK4 was associated with breast cancer
progression [24]. Taken together, the present results
demonstrate that the crosstalk between 4T1 and M2-
Mjs stimulates cell cycle progression of 4T1 cells,
which is probably mediated, at least in part, via the
increased expression of CDK2 and CDK4. Future studies
will be required to determine which cytokines are
responsible for the increased growth of tumor cells.
As a tumor grows, it requires increased amounts of
oxygen, resulting in hypoxia. In response to hypoxia,
HIF-1a accumulates and is translocated into the nucleus,
where it activates the transcription of multiple genes.
Additionally, HIF-1a synthesis is regulated via the activa-
tion of the phosphatidylinositol 3-kinase or mitogen-acti-
vated protein kinase pathways in response to growth
factors and cytokines (reviewed in [25]). HIF-1a leads to
the upregulation of genes involved in certain aspects of
cancer progression, including angiogenesis and metasta-
sis. VEGF-A, which is known as an important mediator
of tumor angiogenesis, is one of the targets of HIF-1a.
Recently, several studies have demonstrated that the
expression of HIF-1a correlates with that of VEGF-C, a
lymphangiogenesis mediator [26,27]. We noted that the
accumulation of HIF-1a in the nuclei of tumor cells and
the expression of VEGF-A and VEGF-C were increased
in mice co-injected with 4T1 cells and M2-Mjs (Figure
2D). It was reported in the 4T1 syngeneic mammary can-
cer model that organ-specific (lung, spleen, liver, bone,
and kidney) metastasis depends on the duration of tumor
implant, and only lung metastasis was observed at 3
weeks after the inoculation of 4T1 cells [10]. We also
noted tumor nodules in the lung at 3 weeks after the 4T1
cell injection. The number and volume of lung tumor
nodules were increased in mice co-injected with 4T1
cells and M2-Mjs (Figure 2A to 2C). The increased
expression of CD31 and lymphatic vessel endothelial hya-
luronan receptor-1 in tumor tissues (Figure 2D) indicates
that tumor angiogenesis and lymphangiogenesis were
increased in mice co-injected with M2-Mjs. These
increases in angiogenesis and lymphangiogenesis may, in
turn, have contributed to increased solid tumor growth
and lung metastasis in animals co-injected with M2-Mjs.
Conclusion
We demonstrated that when M2-Mjs were co-injected
with mammary cancer cells into the mammary fat pads
of Balb/C mice, solid tumor growth and lung metastasis
were increased. The proliferation of cancer cells, the
infiltration of blood leukocytes into tumor tissues, and
activation of HIF-1a were increased, in addition to
angiogenesis and lymphangiogenesis in the tumor tis-
sues when cancer cells were co-injected with M2-Mjs.
Our results indicate that the cross-talk between cancer
cells and M2-Mjs increased the production of chemoat-
tractants and growth factors, which stimulated the infil-
tration of blood monocytes into tumor tissues and the
proliferation of cancer cells, thereby increasing HIF-1a
activation. The activated HIF-1a may also have induced
the transcription of many genes involved in angiogenesis
and lymphangiogenesis.
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